MedPath
NMPA Approval

Pefloxacin Mesylate for Injection

国药准字H20064859

March 25, 2021

Drug Information

注射用甲磺酸培氟沙星

注射剂

200mg(以C17H20FN3O3计)

化学药品

March 25, 2021

Company Information

Applicant Company

Manufacturing Company

苏州工业园区华凌街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲磺酸培氟沙星 - NMPA 批准文号 | MedPath